PRESS RELEASE published on 09/27/2023 at 23:15, 2 years 4 months ago Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations
PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 4 months ago Biophytis et Skyepharma signent un partenariat pour la production de Sarconeos (BIO101)
PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 4 months ago Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 4 months ago Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
PRESS RELEASE published on 09/19/2023 at 07:00, 2 years 4 months ago Biophytis fait le point sur ses programmes d’accès précoce pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 4 months ago Biophytis renforce sa direction avec la nomination de son Chief Business Officer
PRESS RELEASE published on 09/14/2023 at 07:00, 2 years 4 months ago Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 4 months ago Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 09/11/2023 at 07:00, 2 years 4 months ago Biophytis obtient l’autorisation de la FDA pour démarrer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 09/04/2023 at 23:00, 2 years 5 months ago Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
Published on 02/05/2026 at 12:30, 30 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 12:30, 30 minutes ago Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline
Published on 02/05/2026 at 12:00, 1 hour ago Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Published on 02/05/2026 at 09:05, 3 hours 55 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 11 hours 25 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 12:48, 11 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Published on 02/05/2026 at 11:47, 1 hour 13 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 1 hour 14 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 1 hour 30 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 1 hour 30 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 55 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 18 hours 55 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 19 hours 15 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
